CN207832808U - Blood grouping test tube - Google Patents
Blood grouping test tube Download PDFInfo
- Publication number
- CN207832808U CN207832808U CN201721421230.0U CN201721421230U CN207832808U CN 207832808 U CN207832808 U CN 207832808U CN 201721421230 U CN201721421230 U CN 201721421230U CN 207832808 U CN207832808 U CN 207832808U
- Authority
- CN
- China
- Prior art keywords
- test tube
- monoclonal antibodies
- antibody
- coated
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 115
- 239000008280 blood Substances 0.000 title claims abstract description 115
- 238000012360 testing method Methods 0.000 title claims abstract description 109
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 52
- 239000003146 anticoagulant agent Substances 0.000 claims description 7
- 229940127219 anticoagulant drug Drugs 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 229920003023 plastic Polymers 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 claims 1
- 238000010586 diagram Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 239000004568 cement Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000011435 rock Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 238000010422 painting Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model discloses a kind of Blood grouping test tube comprising the inner wall of the test tube body of transparent setting, the test tube body is coated with anti-A monoclonal antibodies, anti-B monoclonal antibodies, anti-D monoclonal antibodies and anti erythrocyte antibody.Technical solutions of the utility model are intended to the step of simplifying bracket for blood grouping.
Description
Technical field
The utility model is related to medical apparatus technical field, more particularly to a kind of Blood grouping test tube.
Background technology
Currently, well known bracket for blood grouping is that the blood for extracting detected person is put into test tube, then blood is extracted from test tube
Liquid is identified.It is deposited in blood group antigens and serum present on common saline agglutination method or gel microtrabeculae method detection red blood cell
Blood group antibody, according to antigen and antibody there are the case where carry out the judgement of blood group.Conventional method has positive typing method (to use
The standard serum of known antibody checks antigen unknown on red blood cell) and reversed typing method it is (red carefully with the standard of known blood group
Born of the same parents check antibody unknown in serum).But these identification methods are required to by detection reagent, slide, test tube, centrifuge
And the equipment such as microscope, therefore, existing bracket for blood grouping method has that utensil needed for identification is more, and detecting step is complicated asks
Topic.
Utility model content
The main purpose of the utility model is to provide a kind of Blood grouping test tube, it is intended to solve bracket for blood grouping step complexity
Problem.
To achieve the above object, the utility model proposes Blood grouping test tube, include the test tube body of transparent setting, institute
Stating the inner wall of test tube body, to be coated with anti-A monoclonal antibodies, anti-B monoclonal antibodies, anti-D monoclonal antibodies and anti-erythrocyte anti-
Body.
Preferably, in the anti-A monoclonal antibodies, the anti-B monoclonal antibodies, the anti-D monoclonal antibodies and institute
It states in anti erythrocyte antibody；Two of which antibody is coated in concentric circles；Another antibody is coated in two line segments, one end of two line segments
The great circle being separately connected in concentric circles, the other end is separately connected the roundlet in concentric circles, also, two line segments are not overlappingly along big
Round one radially extends；A kind of last antibody is coated in two line segments, and one end of two line segments is separately connected the great circle in concentric circles, separately
One end is separately connected the roundlet in concentric circles, also, two line segments are not radially extended along the another of great circle overlappingly.
Preferably, the anti-D monoclonal antibodies are coated in great circle, and the anti erythrocyte antibody is coated in roundlet, the anti-A
Monoclonal antibody and the anti-B monoclonal antibodies are coated in two line segments.
Preferably, the anti-A monoclonal antibodies are coated with along the transverse direction of the test tube body, the anti-B monoclonal antibodies edge
The longitudinal direction of the test tube body is coated with.
Preferably, the anti-A monoclonal antibodies are coated in letter A shapes, and the anti-B monoclonal antibodies are coated in letter b shape,
The anti-D monoclonal antibodies are coated in alphabetical D-shaped and the anti erythrocyte antibody is coated in letter O shapes.
Preferably, the anti-A monoclonal antibodies, the anti-B monoclonal antibodies, anti-D monoclonal antibodies and described
Anti erythrocyte antibody is applied set on the middle part or upper end of the test tube body.
Preferably, the test tube body is made of plastic material.
Preferably, the Blood grouping test tube further includes end cap, and the end cap is covered on the port of the test tube body.
Preferably, it is in a certain amount of negative pressure of vacuum in the test tube body.
Preferably, it is contained with anti-coagulants in the test tube body.
Technical solutions of the utility model on the inner wall of test tube body by being coated with anti-A monoclonal antibodies, anti-B monoclonals
Antibody, anti-D monoclonal antibodies and anti erythrocyte antibody.In turn, if blood to be identified is A types Rh (D) positive, anti-A Dan Ke
Grand antibody, anti-D monoclonal antibodies and anti erythrocyte antibody will produce reaction, other antibody do not react, and then can be accurate
Judge blood to be identified for A types Rh (D) positives；If blood to be identified is that A types Rh (D) is negative, anti-A monoclonal antibodies and anti-
Erythrocyte antibody (EA) will produce reaction, other antibody do not react, and then can accurately judge blood to be identified for A types Rh (D) the moon
Property.Similarly, if anti-B monoclonal antibodies, anti-D monoclonal antibodies and anti erythrocyte antibody generate reaction, other antibody do not react,
Then blood to be identified is Type B Rh (D) positive；If anti-B monoclonal antibodies and anti erythrocyte antibody generate reaction, other antibody are not
Reaction, then blood to be identified is Type B Rh (D) negative.If A monoclonal antibodies, anti-B monoclonal antibodies, anti-D monoclonal antibodies and
Anti erythrocyte antibody reacts, other antibody do not react, then blood to be identified is AB types Rh (D) positive；If A monoclonals are anti-
Body, anti-B monoclonal antibodies and anti erythrocyte antibody react, other antibody do not react, then blood to be identified is AB types Rh
(D) negative.If anti-D monoclonal antibodies and anti erythrocyte antibody react, other antibody do not react, then blood to be identified is
O-shaped Rh (D) is positive；If only anti erythrocyte antibody reacts, other antibody do not react, then blood to be identified is O-shaped Rh (D)
It is negative.
It can be seen that during bracket for blood grouping, it is only necessary to blood to be detected is put into Blood grouping test tube, then into
Row rocks so that blood to be measured is reacted with opposite antibody, and then the response situation of each antibody is observed and can be obtained
The blood group of blood to be measured.It is simple to reach detecting step as a result, takes less, and improves the effect of Blood grouping efficiency；Also, it is logical
Other detections can still be carried out by crossing the remaining blood sample after the Blood grouping test tube is detected.
Description of the drawings
In order to illustrate the embodiment of the utility model or the technical proposal in the existing technology more clearly, below will be to embodiment
Or attached drawing needed to be used in the description of the prior art is briefly described, it should be apparent that, the accompanying drawings in the following description is only
It is some embodiments of the utility model, for those of ordinary skill in the art, in the premise not made the creative labor
Under, the structure that can also be shown according to these attached drawings obtains other attached drawings.
Fig. 1 is the structural schematic diagram of the utility model Blood grouping test tube first embodiment；
Fig. 2 is the front view of Blood grouping test tube in Fig. 1, wherein blood transportation tube is inserted on end cap；
Fig. 3 is the structural schematic diagram of the utility model Blood grouping test tube second embodiment；
Fig. 4 is the structural schematic diagram of the utility model Blood grouping test tube 3rd embodiment；
Fig. 5 a are the structural schematic diagram of the utility model Blood grouping test tube fourth embodiment；
Fig. 5 b are the structural schematic diagram of the 5th embodiment of the utility model Blood grouping test tube；
Fig. 5 c are the structural schematic diagram of the utility model Blood grouping test tube sixth embodiment；
Fig. 5 d are the structural schematic diagram of the 7th embodiment of the utility model Blood grouping test tube；
Fig. 5 e are the structural schematic diagram of the 8th embodiment of the utility model Blood grouping test tube.
Drawing reference numeral explanation：
| Label | Title | Label | Title |
| 100 | Blood grouping test tube | 110 | Anti- A monoclonal antibodies |
| 120 | Anti- B monoclonal antibodies | 130 | Anti- D monoclonal antibodies |
| 140 | Anti erythrocyte antibody | 150 | Anti-coagulants |
| 200 | Test tube body | 400 | End cap |
| 600 | Through-hole | 800 | Blood transportation tube |
The embodiments will be further described with reference to the accompanying drawings for the realization, functional characteristics and advantage of the utility model aim.
Specific implementation mode
The following will be combined with the drawings in the embodiments of the present invention, carries out the technical scheme in the embodiment of the utility model
Clearly and completely describing, it is clear that described embodiment is only a part of the embodiment of the utility model, rather than all
Embodiment.Based on the embodiments of the present invention, those of ordinary skill in the art are not making creative work premise
Lower obtained every other embodiment, shall fall within the protection scope of the present invention.
It is to be appreciated that the directional instruction (such as up, down, left, right, before and after ...) of institute in the utility model embodiment
It is only used for explaining relative position relation, the motion conditions etc. under a certain particular pose (as shown in the picture) between each component, such as
When the fruit particular pose changes, then directionality instruction also correspondingly changes correspondingly.
In addition, the description for being related to " first ", " second " etc. in the present invention is used for description purposes only, and cannot understand
To indicate or implying its relative importance or implicitly indicate the quantity of indicated technical characteristic.Define as a result, " first ",
The feature of " second " can explicitly or implicitly include at least one of the features.In addition, the technical side between each embodiment
Case can be combined with each other, but must can be implemented as basis with those of ordinary skill in the art, when the combination of technical solution
Conflicting or cannot achieve when occur will be understood that the combination of this technical solution is not present, also not in the requires of the utility model
Protection domain within.
The utility model proposes a kind of Blood grouping test tube in fact.
Referring to figs. 1 to Fig. 5 e, the utility model proposes the test tube sheets of a kind of Blood grouping test tube 100, including transparent setting
The inner wall of body 200, the test tube body 200 is coated with anti-A monoclonal antibodies 110, anti-B monoclonal antibodies 120, anti-D monoclonals
Antibody 130 and anti erythrocyte antibody 140.
Specifically, test tube body 200 is in the setting of the closed tubular in one end, cross-sectional shape can be it is round, rectangle or
Person's polygon etc., it is preferably circular.Secondly, for convenience of observing, test tube body 200 is made into transparent setting, for example, test tube body
200 material can be transparent glass material, transparent plastic cement material etc.；Preferably, it in order to avoid in transportational process, is easy
Test tube body 200 is damaged, therefore uses plastic cement material.
On the other hand, for applying set on the anti-A monoclonal antibodies 110 of 200 inner wall of test tube body, the anti-A monoclonals
Antibody 110 can be adhered in test tube body 200, and it is protein to be primarily due to anti-A monoclonal antibodies 110；The examination of plastic cement material
Pipe is the good carrier of protein antibody, has good adsorption of protein；Corresponding positions before trying inboard wall of tube body silication
It sets and is coated with antibody, cover antibody location again later and carry out silication (or first masking corresponding position carries out inboard wall of test tube silication, then removes
Masking is gone to carry out being coated with antibody)；So after anti-A monoclonal antibodies 110 are coated onto the inner wall of test tube body 200, be protein at
The anti-A monoclonal antibodies 110 divided can be adhered directly on the inner wall of test tube body 200.Wherein, anti-A monoclonal antibodies 110
The mode of being coated with can be a variety of, such as：It is coated in line segment shape, curvilinear be coated with, rounded be coated with, be coated in polygon, be in
Alphabetical shape is coated with, memorial font is coated with or is coated in digital shape.Illustrate herein, anti-A monoclonal antibodies 110 not only limit with it is upper
State it is various be coated with mode, as long as anti-A monoclonal antibodies 110 are coated with by certain after mode is coated with, play label with
The mark pattern of other antibody distinguishes.Similarly, for anti-B monoclonal antibodies 120, anti-D monoclonal antibodies 130 and
Anti erythrocyte antibody 140 be coated with that mode can refer to anti-A monoclonal antibodies 110 be coated with mode, do not repeat one by one herein；And
And anti-A monoclonal antibodies 110, anti-B monoclonal antibodies 120, anti-D monoclonal antibodies 130 and anti erythrocyte antibody 140 are coated with
Different settings can be carried out according to the different demands of user by being formed by the arrangement mode between figure afterwards.But it should be noted that
When anti-A monoclonal antibodies 110, anti-B monoclonal antibodies 120, anti-D monoclonal antibodies 130 and anti erythrocyte antibody 140 are applied
If after the completion, must be able to clearly distinguish each antibody by being respectively coated with mode.
Technical solutions of the utility model on the inner wall of test tube body 200 by being coated with anti-A monoclonal antibodies 110, anti-B
Monoclonal antibody 120, anti-D monoclonal antibodies 130 and anti erythrocyte antibody 140.In turn, if blood to be identified is A types Rh (D)
The positive, then anti-A monoclonal antibodies 110, anti-D monoclonal antibodies 130 and anti erythrocyte antibody 140 will produce reaction, other
Antibody does not react, and then can accurately judge blood to be identified for A types Rh (D) positives；If blood to be identified is A types Rh (D) cloudy
Property, then anti-A monoclonal antibodies 110 and anti erythrocyte antibody 140 will produce reaction, other antibody do not react, and then can be with
Accurately judge blood to be identified for A types Rh (D) feminine genders.Similarly, if anti-B monoclonal antibodies 120, anti-D monoclonal antibodies 130 and
Anti erythrocyte antibody 140 generates reaction, other antibody do not react, then blood to be identified is Type B Rh (D) positive；If anti-B monoclonals
Antibody 120 and anti erythrocyte antibody 140 generate reaction, other antibody do not react, then blood to be identified is Type B Rh (D) negative.
If anti-A monoclonal antibodies 110, anti-B monoclonal antibodies 120, anti-D monoclonal antibodies 130 and anti erythrocyte antibody 140 occur
Reaction, other antibody do not react, then blood to be identified is AB types Rh (D) positive；If anti-A monoclonal antibodies 110, anti-B monoclonals
Antibody 120 and anti erythrocyte antibody 140 react, other antibody do not react, then blood to be identified is AB types Rh (D) cloudy
Property.If anti-D monoclonal antibodies 130 and anti erythrocyte antibody 140 react, other antibody do not react, then blood to be identified
For O-shaped Rh (D) positives；If only anti erythrocyte antibody 140 reacts, other antibody do not react, then blood to be identified is O-shaped
Rh (D) is negative.
It should illustrate, in being stained with anti erythrocyte antibody 140 in test tube body 200, predominantly detect anti-in blood
Original whether fail and test tube body 200 in each antibody whether fail.It illustrates, anti erythrocyte antibody 140 is polyclonal
Antibody, therefore can be reacted with a variety of endoerythrocytic antigens, that is to say, that when anti erythrocyte antibody 140 and red blood cell
After interior antigen is reacted, that is, prove that each antigen in blood is effective.If in test tube body 200 it is nonadherent have it is anti-
Erythrocyte antibody (EA) 140 fails anti-by anti-erythrocyte after the Staphylococal Protein A in blood (citing A type blood is explained) fails
Body 140 detected；Also, in blood Staphylococal Protein A failure also fail to the anti-A monoclonal antibodies 110 in test tube body 200 into
Row reaction, therefore it is O-shaped blood that will judge this blood to be measured by accident.As a result, in being stained with anti erythrocyte antibody in test tube body 200
140 purports are to ensure the accuracy of testing result.Secondly as anti-A monoclonal antibodies 110, anti-B monoclonal antibodies 120, anti-D are mono-
Clonal antibody 130 and the same time of anti erythrocyte antibody 140 are adhered to the inner wall of test tube body 200, and each ingredient is
Therefore protein after anti erythrocyte antibody 140 can be reacted with the antigen in blood, i.e., shows that anti-A monoclonals are anti-indirectly
Body 110, anti-B monoclonal antibodies 120 and anti-D monoclonal antibodies 130 also do not fail.
It can be seen that during bracket for blood grouping, it is only necessary to put blood to be detected in Blood grouping test tube 100 into, so
It is rocked afterwards so that blood to be measured is reacted with opposite antibody, and then the response situation of each antibody is observed
Obtain the blood group of blood to be measured.It is simple to reach detecting step as a result, takes less, and improves the effect of Blood grouping efficiency；And
And the remaining blood sample after being detected by the Blood grouping test tube 100 can still carry out other detections.
In another embodiment, referring to Figures 1 and 2, in the anti-A monoclonal antibodies 110, the anti-B monoclonal antibodies
120, in the anti-D monoclonal antibodies 130 and the anti erythrocyte antibody 140；Two of which antibody is coated in concentric circles；Again
A kind of antibody is coated in two line segments, and one end of two line segments is separately connected the great circle in concentric circles, and the other end is separately connected concentric circles
In roundlet, also, two line segments one radially extending not overlappingly along great circle；A kind of last antibody is coated in two line segments, and two
One end of line segment is separately connected the great circle in concentric circles, and the other end is separately connected the roundlet in concentric circles, also, two line segments do not weigh
It is radially extended foldedly along the another of great circle.
Specifically, in four kinds of antibody (anti-A monoclonal antibodies 110, anti-B monoclonal antibodies 120, anti-D monoclonal antibodies 130
And anti erythrocyte antibody 140) in, it chooses the painting of any one antibody and is set as great circle shape.Secondly, the institute after being coated with big round
In remaining three kinds of antibody, a kind of antibody painting is arbitrarily taken to be set as small circular shape, and roundlet is arranged with aforementioned great circle for concentric circles.Again
Person in two kinds of antibody of residue after being coated with roundlet, then arbitrarily chooses a kind of antibody and makees two lines section and be coated with, two lines section
One end is separately connected great circle, and the other end is separately connected roundlet, and overlappingly along a diameter of great circle, (first is not straight for two lines section
Diameter) direction extension.Finally, a kind of remaining antibody is also made two line segments to be coated with, one end of two lines section is separately connected great circle, separately
One end is separately connected roundlet, and two lines section does not extend along another diameter (second diameter) direction of great circle overlappingly.It should
Illustrate, first diameter is arranged with second diameter in the angle that the number of degrees are not zero.It should be understood that making the label figure of the present embodiment
Case is arranged, convenient for observation and memory.
Further, referring to Fig.1, the anti-D monoclonal antibodies 130 are coated in great circle, and the anti erythrocyte antibody 140 is in
Roundlet is coated with, and the anti-A monoclonal antibodies 110 and the anti-B monoclonal antibodies 120 are coated in two line segments.It illustrates, resists
D monoclonal antibodies 130 are coated with along big round, and anti erythrocyte antibody 140 is coated with along roundlet shape, and great circle is in concentric with roundlet
Circle setting；Furthermore anti-A monoclonal antibodies 110 are coated with along a diameter (first diameter) for great circle, and anti-B monoclonal antibodies 120 are along big
Round another diameter (second diameter) is coated with, also, first diameter is not arranged with second diameter in the number of degrees for 0 angle.
On the basis of the above embodiments, it is contemplated that, if the angle of first diameter and second diameter is smaller, that is, two straight
The spacing of diameter is smaller, and then is not easy to observe.Therefore, further, by the anti-A monoclonal antibodies 110 along the test tube sheet
The transverse direction of body 200 is coated with, and the anti-B monoclonal antibodies 120 are coated with along the longitudinal direction of the test tube body 200.It is namely straight by two
Diameter is arranged two special positions, and then facilitates observation and memory.
In yet another embodiment, with reference to Fig. 3, the anti-A monoclonal antibodies 110 are coated in letter A shapes, the anti-B Dan Ke
Grand antibody 120 is coated in letter b shape, and the anti-D monoclonal antibodies 130 are coated in alphabetical D-shaped and the anti erythrocyte antibody
140 are coated in letter O shapes.It is coated with it should be understood that corresponding antibody is made corresponding letter, and then facilitates memory and later stage
Blood group judges.It is coated with it is of course also possible to which any antibody is made any letter shape, as long as arbitrary two antibody is coated with the letter to be formed
Shape difference.
With reference to Fig. 4, in a further preferred embodiment, the anti-A monoclonal antibodies 110, the anti-B monoclonal antibodies 120,
The anti-D monoclonal antibodies 130 and anti erythrocyte antibody 140 are that concentric circles is coated with, and each diameter of a circle is in successively decrease successively
Setting.Namely anti-A monoclonal antibodies 110 are coated with that the diameter of a circle to be formed is maximum, and anti erythrocyte antibody 140 is coated with the circle to be formed
Diameter it is minimum.It is appreciated that this pattern is provided with conducive to the observation and memory in detection process.It should be noted that each antibody
It is coated with the diameter of a circle to be formed and can arbitrarily be arranged and (do not limit that be coated with the diameter of a circle that is formed by anti-A monoclonal antibodies 110 maximum
Or minimum etc.), as long as arbitrary two diameter of a circle is not equal.
In another embodiment, with reference to Fig. 5 a to Fig. 5 e, the anti-A monoclonal antibodies 110, the anti-B monoclonals
Antibody 120, the anti-D monoclonal antibodies 130 and anti erythrocyte antibody 140 are coated in four line segments of ordered arrangement.It should
Illustrate, line segment can be along the axis direction ordered arrangement of test tube body 200, can also be along the circumferential orderly row of test tube body 200
Row；Secondly, the length of line segment can be consistent, can also be in that orderly gradual change is arranged or in unordered variation.
Further, the anti-A monoclonal antibodies 110, the anti-B monoclonal antibodies 120, the anti-D monoclonal antibodies
130 and the anti erythrocyte antibody 140 apply middle part or upper end set on the test tube body 200.It should be understood that
During bracket for blood grouping, need blood being delivered in test tube body 200, after then being rocked to test tube body 200, then
The response situation of each antibody is observed and then is judged, with the blood group of determination blood to be measured.If each antibody is applied as a result,
Be located at the lower end of test tube body 200, in the case that blood volume to be measured is larger, be coated with antibody can be flooded, into without
Convenient for the observation of reaction result.
In another embodiment, referring to Fig.1, the Blood grouping test tube 100 further includes end cap 400, and the end cap 400 covers
Set on the port of the test tube body 200.It should be understood that it is provided with the port that end cap 400 is covered on test tube body 200,
One：When Blood grouping test tube 100 is not used, end cap 400 can be sealed test tube body 200, and then extend each antibody
Validity；Secondly：Effectively impurity or grieshoch is avoided to enter in test tube body 200；Third, during detecting blood group, blood is conveyed
After liquid to test tube body 200, need to rock test tube body 200 to ensure that blood is contacted with each antibody, in turn,
During rocking, end cap 400 plays the role of sealing, to effectively prevent blood to be revealed.
Also it should be noted that the middle part of end cap 400 is provided with through-hole 600, through-hole 600 is covered by a rubber layer.It can
With understanding, blood transportation tube 800 is stretched by piercing through rubber layer 200 in test tube body, and in turn, blood to be measured can be direct
By blood transportation tube 800 to enter test tube body 200.In this regard, during blood testing, without first end cap 400 is beaten
It opens, then blood is delivered to test tube body 200, in turn, significantly simplify operation and the step of detection work.Also, work as blood
After liquid enters test tube body 200, due to end cap 400 and the close fit of delivery pipe, directly Blood grouping test tube 100 can be carried out
It rocks, the phenomenon that blood leakage will not occur.Wherein, through-hole 600 is sealed using rubber layer：First, rubber layer is close
Sealing property is good；Secondly：After blood transportation tube 800 pierces through rubber layer and stretches into test tube body 200, since rubber layer itself has
Elasticity, therefore, rubber layer and the tube wall of blood transportation tube 800 directly will present the state fitted closely.
Further, it is in a certain amount of negative pressure of vacuum in the test tube body 200.It is appreciated that test tube body 200
Inside carries out partial vacuum processing so that has certain draught head between the inside and the external world of test tube body 200.In turn,
On the basis of a upper embodiment, after blood transportation tube 800 is inserted into test tube body 200, due to the presence of draught head, blood meeting
It automatically flows into test tube body 200.The detecting step of blood is significantly simplified as a result,.
Further, with reference to Fig. 2, anti-coagulants 150 is contained in the test tube body 200.It should be understood that in advance will
After anti-coagulants 150 is put into test tube body 200, then will with during blood testing, not having to separately first open end cap 400
Anti-coagulants 150 is put into, to simplify detecting step.Secondly, on the basis of the above embodiments, blood conveying is inserted on end cap 400
Pipe 800, so, if during detecting blood, the opening of end cap 400 is separately then placed in anti-coagulants 150, step is number
It is tired.For comparing the two as a result, the present embodiment plays the effect of simplified detecting step.
The above is only the preferred embodiment of the present invention, and it does not limit the scope of the patent of the present invention,
It is every under the inventive concept of the utility model, equivalent structure made based on the specification and figures of the utility model becomes
It changes, or directly/be used in other related technical areas indirectly and be included in the scope of patent protection of the utility model.
Claims (10)
1. a kind of Blood grouping test tube, which is characterized in that include the test tube body of transparent setting, the inner wall of the test tube body applies
Equipped with anti-A monoclonal antibodies, anti-B monoclonal antibodies, anti-D monoclonal antibodies and anti erythrocyte antibody；
Wherein, the anti-A monoclonal antibodies, anti-B monoclonal antibodies, anti-D monoclonal antibodies and anti erythrocyte antibody are applied
If after the completion, can clearly distinguish each antibody by being coated with mode.
2. Blood grouping test tube as described in claim 1, which is characterized in that mono- in the anti-A monoclonal antibodies, the anti-B
In clonal antibody, the anti-D monoclonal antibodies and the anti erythrocyte antibody；Two of which antibody is coated in concentric circles；Again
A kind of antibody is coated in two line segments, and one end of two line segments is separately connected the great circle in concentric circles, and the other end is separately connected concentric circles
In roundlet, also, two line segments one radially extending not overlappingly along great circle；A kind of last antibody is coated in two line segments, and two
One end of line segment is separately connected the great circle in concentric circles, and the other end is separately connected the roundlet in concentric circles, also, two line segments do not weigh
It is radially extended foldedly along the another of great circle.
3. Blood grouping test tube as claimed in claim 2, which is characterized in that the anti-D monoclonal antibodies are coated in great circle, institute
It states anti erythrocyte antibody to be coated in roundlet, the anti-A monoclonal antibodies and the anti-B monoclonal antibodies are coated in two line segments.
4. Blood grouping test tube as claimed in claim 3, which is characterized in that the anti-A monoclonal antibodies are along the test tube sheet
The transverse direction of body is coated with, and the anti-B monoclonal antibodies are coated with along the longitudinal direction of the test tube body.
5. Blood grouping test tube as described in claim 1, which is characterized in that the anti-A monoclonal antibodies are applied in letter A shapes
If the anti-B monoclonal antibodies are coated in letter b shape, the anti-D monoclonal antibodies are in that alphabetical D-shaped is coated with and described anti-red
Cell antibody is coated in letter O shapes.
6. Blood grouping test tube as described in claim 1, which is characterized in that the anti-A monoclonal antibodies, the anti-B Dan Ke
Grand antibody, the anti-D monoclonal antibodies and the anti erythrocyte antibody apply set on the test tube body middle part or on
End.
7. Blood grouping test tube as described in claim 1, which is characterized in that the test tube body is made of plastic material.
8. the Blood grouping test tube as described in claim 1 to 7 any one, which is characterized in that the Blood grouping test tube is also
Including end cap, the end cap is covered on the port of the test tube body.
9. Blood grouping test tube as claimed in claim 8, which is characterized in that be in partial vacuum negative pressure in the test tube body.
10. Blood grouping test tube as claimed in claim 8, which is characterized in that be contained with anti-coagulants in the test tube body.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201721421230.0U CN207832808U (en) | 2017-10-30 | 2017-10-30 | Blood grouping test tube |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201721421230.0U CN207832808U (en) | 2017-10-30 | 2017-10-30 | Blood grouping test tube |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN207832808U true CN207832808U (en) | 2018-09-07 |
Family
ID=63384627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201721421230.0U Expired - Fee Related CN207832808U (en) | 2017-10-30 | 2017-10-30 | Blood grouping test tube |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN207832808U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114939450A (en) * | 2022-06-13 | 2022-08-26 | 广州金域医学检验中心有限公司 | Test tube and anti-overflow interpretation method thereof |
-
2017
- 2017-10-30 CN CN201721421230.0U patent/CN207832808U/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114939450A (en) * | 2022-06-13 | 2022-08-26 | 广州金域医学检验中心有限公司 | Test tube and anti-overflow interpretation method thereof |
| CN114939450B (en) * | 2022-06-13 | 2023-10-10 | 广州金域医学检验中心有限公司 | Test tube and test tube overflow-preventing interpretation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11047844B2 (en) | Electronic analyte assaying device | |
| AU2014238176B2 (en) | Diagnostic test device with improved structure | |
| CN104820104A (en) | Human chorionic gonadotropin immunochromatography detection test paper and preparation method thereof | |
| CN207832808U (en) | Blood grouping test tube | |
| CN201053967Y (en) | Quick detection reagent kit for blood type and transfusion matching type | |
| CN114441766A (en) | Fluorescent immunochromatographic test strip for quantitatively detecting anti-PLA 2R antibody and preparation method thereof | |
| US20110097820A1 (en) | Swab-Based Diagnostic Systems | |
| CN105004855B (en) | A kind of lateral flow detects test-strips | |
| CN108519483A (en) | Based on the platelet antibody detection kit and its detection method of solid agglutination method and application | |
| CN208969109U (en) | The Rapid detection test strip adulterated for goat milk | |
| CN201945590U (en) | A detecting device with immune test paper strip | |
| CN106053824A (en) | Pancreas cancer duplex detection kit | |
| CN210269872U (en) | Human blood group antigen detection device | |
| CN205301335U (en) | Many toxin ally oneself with colloidal gold method test -bottle who surveys | |
| CN108802402A (en) | A kind of kit of quick discriminating respiratory tract infection type and its application | |
| CN207440112U (en) | A kind of new microtrabeculae blood type card | |
| CN209102728U (en) | A kind of microtrabeculae agglutination antihuman globulin detection card | |
| CN103884849A (en) | Display manner of determination results of blood type and blood type antibody and manufacturing method | |
| CN102879562A (en) | Colloidal gold immunofiltration quantitive detection method and reagent kit | |
| CN208420951U (en) | A kind of portable inspectiont blood group plate | |
| CN202013354U (en) | Detection box used for immune chromatography detection technology | |
| CN107727625A (en) | A kind of self-test card of fluorescence immunity analyzer and preparation method thereof | |
| CN206103021U (en) | Intelligence peritoneal drainage bag | |
| CN208795746U (en) | Platelet antibody detection kit based on solid agglutination method | |
| CN102539749A (en) | Field high-sensitivity immunoassay method and kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180907 |